Alpha-tocopherol but not beta-tocopherol inhibits thrombin-induced PKC activation and endothelin secretion in endothelial cells

Journal of Cardiovascular Risk

Volumn 5, Issue 5, 1998, Pages 339-345

  Martin Nizard, Françoise ^a   Boullier, Agnès ^a   Fruchart, Jean Charles ^a   Duriez, Patrick ^a  

^a INSERM   (France)

Author keywords

Endothelial cells; Endothelin; Protein kinase C; Thrombin; tocopherol; tocopherol

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BETA TOCOPHEROL; ENDOTHELIN; PROTEIN KINASE C; THROMBIN;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; AORTA; ARTICLE; CATTLE; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME ACTIVATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0032446835     PISSN: 13506277     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043798-199810000-00010     Document Type: Article

References (50)

1. Yanigasawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332:411-415.
2. Dubin D, Pratt RE, Cooke JE, Dzau VJ. Endothelin, a potent vasoconstrictor, is a vascular smooth muscle mitogen. J Vasc Med Biol 1989; 1:150-154.
3. Achmad TH, Rao GS. Chemotaxis of human blood monocytes towards endothelin-1 and the influence of calcium channel blockers. Biochem Biophys Res Commun 1992; 189:994-1000.
4. McCarron RM, Wang L, Stanimirovic DB, Spatz M. Endothelin induction of adhesion molecule expression on human brain microvascular endothelial cells. Neurosci Lett 1993; 156:31-34.
5. Winkles JA, Alberts GF, Brogi E, Libby R Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries. Biochem Biophys Res Commun 1993; 191:1081-1088.
6. Lerman A, Edwards BS, Hallett JW, Heublin DM, Sanberg SM, Burnett JC. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991; 325:997-1001.
7. Zeiher AM, Ihling C, Pistorius K, Schächinger V, Schaefer H-E. Increased tissue endothelin immunoreactivity in atherosclerotic lesions associated with acute coronary syndromes. Lancet 1994; 344:1405-1406.
8. Ihling C, Göbel HR, Lippold A, Wessels S, Paul M, Schaefer HE, Zeiher AM. Endothelin-1 -like immunoreactivity in human atherosclerotic coronary tissue: a detailed analysis of the cellular distribution of endothelin-1. J Pathol 1996; 179:303-308.
9. Jones GT, van Rij AM, Solomon C, Thomson IA, Packer SGK. Endothelin-1 is increased overlying atherosclerotic plaques in human arteries. Atherosclerosis 1996; 124:25-35.
10. Schini VB, Hendrickson H, Heublein DM, Burnett JC Jr, Vanhoutte PM. Thrombin enhances the release of endothelin from cultured porcine aortic endothelial cells. Eur J Pharmacol 1989; 165:333-334.
11. Kohno M, Yasunari K, Yolokawa K, Murakawa Kl, Horio T, Kanayama Y, et al. Thrombin stimulates the production of immunoreactive endothelin-1 in cultured human umbilical vein endothelial cells. Metabolism 1990; 39:1002-1005.
12. Kohno M, Yokokawa K, Horio T, Yasunari K, Murakawa KI, Ikeda M, Takeda T. Release mechanism of endothelin-1 and big endothelin-1 after stimulation with thrombin in cultured porcine endothelial cells. J Vasc Res 1992; 29:56-63.
13. Marsen TA, Simonson MS, Dunn MJ. Thrombin induces the preproendothelin-1 gene in endothelial cells by protein tyrosine kinaselinked mechanism. Circ Res 1995; 76:987-995.
14. Riemersma RA, Wood DA, Macintyre CCH, Elton RA, Gey KF, Oliver M. Risk of angina pectoris and plasma concentrations of vitamins A, C, E and carotene. Lancet 1991; 337:1-5.
15. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328:1450-1456.
16. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willnett W. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993; 328:1444-1449.
17. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347:781-786.
18. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991; 88:1785-1792.
19. Dieber-Rotheneder M, Puhl H, Waeg H, Striegl G, Esterbauer H. Effect of oral supplementation with D-alpha-tocopherol on vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res 1991; 32:1325-1332.
20. Keaney JF, Gaziano JM, Xu A, Fret B, Curran-Celentano J, Shwaery GT, et al. Low-dose a-tocopherol improves and high-dose a-tocopherol worsens endothelial vasodilator function in cholesterol fed rabbits. J Clin Invest 1994; 93:844-851.
21. Faruqi R, de la Motta C, DiCorleto P. Alpha-tocopherol inhibits agonistinduced monocytic cell adhesion to cultured human endothelial cells. J Clin Invest 1994; 94:592-600.
22. Navab M, Imes SS, Hama SY, Hough GP, Ross LA, Borck RW, et al. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest 1991; 88:2039-2046.
23. Hennig B, Enoch C, Chow CK. Protection by vitamin E against endothelial cell injury by linoleic acid hydroperoxides. Nutr Res 1987; 7:1253-1260.
24. Keaney JF, Guo Y, Cunningham D, Shwaery GT, Xu A, Vita JA. Vascular incorporation of a-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation. J Clin Invest 1996; 98:386-394.
25. Tasinato A, Boscoboinik D, Bartoli GM, Maroni P, Azzi A. d-α-Tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc Natl Acad Sei USA 1995; 92:12190-12194.
26. Azzi A, Boscoboinik D, Marilley D, Özer NK, Stäuble B, Tasinato A. Vitamin E: a sensor and an information transducer of the cell oxidation state. Am J Clin Nutr 1995; 62 (suppl):1337S-1346S.
27. Hattori Y, Kasai K, Banba N, Hattori S, Nakamura T, Shimoda S-I. Effect of a phorbol ester on immunoreactive endothelin-1 release from cultured porcine aortic endothelial cells. Endocrinol Japon 1992; 39:341-345.
28. Kitazumi K, Tasaka K. The role of c-June protein in thrombin-stimulated expression of preproendothelin-1 mRNA in porcine aortic endothelial cells. Biochem Pharmacol 1996; 46:455-464.
29. Petersen G. A simplification of the protein assay method of Lowry which is more generally applicable. Anal Biochem 1977; 83:346-356.
30. Haller, H. Ziegler W, Lindschau C, Luft FC. Endothelial cell tyrosine kinase receptor and G protein-coupled receptor activation involves distinct protein kinase C isoforms. Arterioscler Thromb Vasc Biol 1993; 16:678-686.
31. Marsden PA, Brenner BM. Transcriptional regulation of the endothelin-1 gene by TNF-α. Am J Physiol 1992; 262:C854-C861.
32. Emori T, Hirata Y, Ohta K, Shichiri M, Marumo F. Secretory mechanisms of immunoreactive endothelin in cultured bovine endothelial cells. Biochem Biophys Res Commun 1989; 160:93-100.
33. Freedman JE, Farhat JH, Loscalzo J, Keaney JF. α-Tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation 1996; 94:2434-2440.
34. Ricciarelli R, Tasinato A, Clement S, Ozer NK, Boscoboinik D, Azzi A. Alpha-tocopherol specifically inactivates cellular protein kinase C by changing its phosphorylation state. Biochem J 1998; 334:243-249.
35. Inoue A, Yanagisawa M, Takuwa Y, Mitsui Y, Kobayashi M, Masaki T. The human preproendothelin-1 gene. J Biol Chem 1989; 264:14954-14959.
36. Trejo J, Chambard JC, Karin M, Brown JH. Biphasic increase in c-jun mRNA is required for induction of AP-1 mediated gene transcription: differential effects of muscarinic and thrombin receptor activation. Mol Cell Biol 1992; 12:4742-4750.
37. Bohmann D, Bos TJ, Admon A, Nishimura T, Vogt PK, Tijan R. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 1987; 238:1386-1392.
38. Lee W, Mitchell P, Tijan R. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 1987; 49:741-752.
39. Azzi A, Boscoboinik D, Fazzio A, Marilley D, Maroni P, Ozer NK, et al. RRRalpha-tocopherol regulation of gene transcription in response to the cell oxidant status. Z Ernahrungwiss 1998; 37 (suppl 1):21-28.
40. Pryor AW, Cornicelli JA, Deval LJ, Tait B, Trivedi BK, Witiak DT, et al. A rapid screening test to determine the antioxidant potencies of natural and synthetic antioxidants. J Org Chem 1994; 58:3521-3532.
41. Bierhaus A, Chevion S, Chevion M, Hofmann M, Queherberger P, Illmer T, et al. Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes 1997; 46:1481-1490.
42. Annather D, Millan MT, Palmetshofer A, Robson SC, Geczy C, Richie AJ, et al. Thrombin activates nuclear factor-Kappa B and potentiates endothelial cell activation by TNF. J Immunol 1997; 159:5620-5628.
43. Das KC, White CW. Activation of NF-Kappa B by antineoplastic agents. Role of protein kinase C. J Biol Chem 1997; 272:14914-14920.
44. Sugiyama S, Kugiyama K, Ogata N, Doi H, Ota Y, Ohgushi M, et al. Biphasic regulation of transcription factor nuclear factor kappa B activity in human endothelial cells by lysophosphatidyl choline through protein kinase C mediated pathway. Arterioscler Thromb Vase Biol 1998; 18:568-576.
45. Barchowsky A, Munro SR, Morana SJ, Vincenti MP, Treadwell M. Oxidantsensitive and phosphorylation-dependent activation of NF-kappa B and AP-1 in endothelial cells. Am J Physiol 1996; 269:L829-L836.
46. Suzuki YJ, Packer LL. Inhibition of NF-kappa B binding activity by alphatocopheryl succinate. Biochem Mol Biol Int 1993; 4:693-700.
47. Boulanger CM, Tanner FC, Bea ML, Hahn AW, Werner A, Lusher TF. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res 1992; 70:1191-1197.
48. Maziere C, Auclair M, Djavaheri-Mergny M, Packer L, Maziere JC. Oxidized low-density lipoprotein induces activation of transcription factor NF-kappa B in fibroblasts endothelial and smooth muscle cells. Biochem Mol Biol Int 1995; 39:1201-1207.
49. Maziere C, Djavaheri-Mergny M, Frey-Fressart V, Delattre J, Maziere JC. Copper and cell-oxidized low-density lipoprotein induces activation protein 1 in fibroblasts, endothelial and smooth muscle cells. FEBS Lett 1997; 409:351-356.
50. Chen TH, Tsen HP, Yang JY, Mao SJ. Effect of antioxidant in endothelial cells exposed to oxidized low density lipoproteins. Life Sci 1998; 62:PL277-PL282.